Estradiol stimulates capillary formation by human endothelial progenitor cells: Role of estrogen receptor-α/β, heme oxygenase 1, and tyrosine kinase

Hypertension

Volumn 56, Issue 3, 2010, Pages 397-404

  Baruscotti, Isabella ^a   Barchiesi, Federica ^a   Jackson, Edwin K ^c   Imthurn, Bruno ^a   Stiller, Ruth ^a   Kim, Jai Hyun ^d   Schaufelberger, Sara ^a   Rosselli, Marinella ^a   Hughes, Christopher C W ^d   Dubey, Raghvendra K ^b,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cardiovascular disease; endothelial progenitor cells; estradiol; estrogen receptors; hormone replacement therapy; vascular remodeling

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; DIARYLPROPIONITRILE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HEME OXYGENASE 1; PROTEIN TYROSINE KINASE; SEMAXANIB;

ARTICLE; CAPILLARY PROLIFERATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ESTROGEN ACTIVITY; HORMONAL REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STEM CELL;

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CAPILLARIES; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FLOW CYTOMETRY; HEME OXYGENASE-1; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 77955980792     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.110.153262     Document Type: Article

References (23)

1. Dubey RK, Jackson EK. Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms. Am J Physiol Renal Physiol. 2001;280:F365-F388.
2. Dubey RK, Imthurn B, Barton M, Jackson EK. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res. 2005;66:295-306.
3. Clarkson TB, Appt SE. Coronary artery disease and postmenopausal hormone therapy: is there a time for prevention? Gynaecol Forum. 2004; 9:11-14.
4. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev. 2008;60:210-241.
5. Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP. Estrogen in the prevention of atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001;135:939-953.
6. Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340:1801-1811.
7. Losordo DW, Inser JM. Estrogen and angiogenesis: a review. Arterioscler Thromb Vasc Biol. 2001;21:6-12.
8. Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17/3-estradiol and norethisterone acetate: a two-year follow-up study. Hypertension. 1995;25:848-853.
9. Dzau VJ, Gnecchi M, Pachori AS, Morello F, Melo LG. Therapeutic potential of endothelial cells in cardiovascular diseases. Hypertension. 2005;46:7-18.
10. Pare G, Krust A, Karas RH, Dupont S, Aronovitz M, Chambon P, Mendelsohn ME. Estrogen receptor-a mediates the protective effects of estrogen against vascular injury. Circ Res. 2002;90:1087-1092.
11. Zhu Y, Bian Z, Lu P, Karas RH, Bao L, Cox D, Hodgin J, Shaul PW, Thoren P, Smithies O, Gustafsson JA, Mendelsohn ME. Abnormal vascular function and hypertension in mice deficient in estrogen receptor-/3. Science. 2002;295:505-508.
12. Ogawa S, Emi M, Hosoi T, Ouchi Y, Inoue S. Association of estrogen receptor/3(ESR2) gene polymorphism with blood pressure. J Hum Genet. 2000;45:327-330.
13. Dulak J, Deshane J, Jozkowicz A, Agarwal A. Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis. Circulation. 2008;117:231-241.
14. Nath KA. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int. 2006;70:432-443.
15. Fang J, Sawa T, Akaike T, Akuta T, Sahoo SK, Khaled G, Hamada A, Maeda H. In vivo antitumor activity of pregylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. Cancer Res. 2003; 63:3567-3574.
16. Harris HA, Katzenellenbogen JA, Katzenellenbogen BS. Characterization of the biological roles of the estrogen receptors, ERa and ER/3, in estrogen target tissues in vivo through the use of an ERa-selective ligand. Endocrinology. 2002;143:4172-4177.
17. Deshane J, Chen S, Caballero S, Grochot-Przeczek A, Was H, Calzi SL, Lach R, Hock TD, Chen B, Hill-Kapturczak N, Siegal GP, Dulak J, Jozkowicz A, Grant MB, Agarwal A. Stromal cell-derived factor-1 promotes angiogenesis via a heme oxygenase 1-sependent mechanism. J Exp Med. 2007;204:605-618.
18. Volti L, Sacerdoti GD, Sangras B, Vanella A, Mezentsev A, Ssapagnini G, Palck JR, Abraham NG. Carbon monoxide signalling in promoting angiogenesis in human microvessel endothelial cells. Antioxid Redox Signal. 2005;7:704-710.
19. Dulak J, Loboda A, Jozkowicz A. Effect of heme oxygenase-1 on vascular function and disease. Curr Opin Lipidol. 2008;19:505-512.
20. Meyer MR, Haas E, Prossnitz ER, Barton M. Non-genomic regulation of vascular cell function and growth by estrogen. Mol Cell Endocrinol. 2009;308:9-16.
21. Garvin S, Nilsson UW, Dabrosin C. Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1 and VEGFR-2 in breast cancer and endothelial cells. British J Cancer. 2005;93:1005-1010.
22. Koehne P, Willam C, Strauss E, Schindler R, Eckardt R-U, Bührer C. Lack of hypoxic stimulation of VEGF secretion from neutrophils and platelets. Am J Physiol Circ Physiol. 2000;279:H817-H824.
23. Hamada H, Kim MK, Iwakura A, Ii M, Thorne T, Qin G, Asai J, Tsutsumi Y, Sekiguchi H, Silver M, Wecker A, Bord E, Zhu Y, Kisore R, Losordo DW. Estrogen recptors a and/3 mediate contrinution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation. 2006;114:2261-2270.